Dark

Check out our Dark Pool Levels

CRRTF
CRESCITA THERAPEUTICS ORD
stock OTC

Inactive

Feb 18, 2025

0.3901USD-0.332%(-0.0013)3,025

Pre-market

0.00USD-100.000%(-0.39)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Dec 15, 2021

07:45AM EST Crescita Therapeutics Announces Renewal of Normal Course Issuer Bid Business Wire

Dec 13, 2021

07:30AM EST Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharmaceuticals for Pliaglis(r) Business Wire

Nov 11, 2021

07:35AM EST Crescita Therapeutics Q3 Loss Per Share C$0.04 Vs Profit C$0.19 Last Year RTTNews

07:30AM EST Crescita Reports Third Quarter 2021 Results and Appoints New Board Member Business Wire

Sep 9, 2021

07:37AM EDT Crescita Therapeutics Announces Canadian Distribution Agreement With Obagi Cosmeceuticals RTTNews

07:30AM EDT Crescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC Business Wire

Sep 7, 2021

07:34AM EDT Crescita Therapeutics Completes Acquisition Of Minority Interest In Akyucor RTTNews

07:30AM EDT Crescita Acquires Minority Interest in The Best You(r) Business Wire

Aug 18, 2021

07:48AM EDT Crescita Therapeutics And STADA Enter 15-Country Exclusive Licensing Deal For Pliaglis RTTNews

07:45AM EDT Crescita Therapeutics and STADA Enter 15-Country Exclusive Licensing Agreement for Pliaglis(r) Business Wire

Jun 28, 2021

07:30AM EDT Crescita Therapeutics Announces 9-Country Licensing Agreement with Croma Pharma for Pliaglis(r) Business Wire

May 12, 2021

07:30AM EDT Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders Business Wire

May 11, 2021

07:30AM EDT Crescita Reports First Quarter 2021 Results Business Wire

Apr 13, 2021

03:15PM EDT Crescita Therapeutics to Present at the 2021 Bloom Burton & Co. Healthcare Investor Conference Business Wire

Jan 21, 2021

07:31AM EST Crescita Announces Filing of New Medical Device License PR Newswire

Nov 26, 2020

07:30AM EST Crescita Therapeutics Announces Approval of Normal Course Issuer Bid PR Newswire

Nov 12, 2020

07:58AM EST Crescita Therapeutics Q3 Net Income Rises To C$4.21 Mln From C$88K Prior Year RTTNews

07:31AM EST Crescita Reports Third Quarter 2020 Results PR Newswire

Nov 5, 2020

07:31AM EST Crescita Announces Licensing Agreement for Pliaglis(r) in China PR Newswire

Aug 12, 2020

07:43AM EDT Crescita Therapeutics Q2 Loss Per Share C$0.15 Vs Profit C$0.10 Last Year RTTNews

07:31AM EDT Crescita Reports Second Quarter 2020 Results PR Newswire

Jul 28, 2020

07:30AM EDT Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis(r) PR Newswire

Share